Välkommen till Svenska GyncancergruppenWelcome to the Swedish Gynecologic Cancer Group
We are dedicated to continued research about gynecologic cancer in order to save and improve women's lives
The Swedish Gynecologic Cancer Group (SweGCG) was founded in 2013 and is a national research group for collaboration on clinical studies of gynecologic cancer diseases.
The aim of SweGCG is to initiate and conduct clinical and translational studies of high scientific quality through national and international cooperation. The studies should be based on, but not limited to, the Swedish Quality Registry for Gynecologic Cancer.
SweGCG is supported financially by the Swedish Cancer Society.
Latest news and publications
Long-term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study.
Flöter Rådestad A, Dahm-Kähler P, Holmberg E, Bjurberg M, Hellman K, Högberg T, Kjölhede P, Marcickiewicz J, Rosenberg P, Stålberg K, Åvall-Lundqvist E, Borgfeldt C
Acta Obstet Gynecol Scand Acta Obstet Gynecol Scandinfo
2022 May 27
The wait time to primary surgery in endometrial cancer - impact on survival and predictive factors: a population-based SweGCG study
Marcickiewicz J, Åvall-Lundqvist E, Holmberg ECV, Borgfeldt C, Bjurberg M, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Högberg T, Rosenberg P, Stålberg K, Kjølhede P.
Acta Oncol. 2022 Jan;61(1):30-37. doi: 10.1080/0284186X.2021.1992006. Epub 2021 Nov 5.
2021 Nov 05
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) study.
Borgfeldt C, Holmberg E, Marcickiewicz J, Stålberg K, Tholander B, Lundqvist EÅ, Flöter-Rådestad A, Bjurberg M, Dahm-Kähler P, Hellman K, Hjerpe E, Kjölhede P, Rosenberg P, Högberg T
2021 Jun 02